Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18686ExperimentalProtein Based Therapies
MBP134 is a pan-ebolavirus cocktail comprising two broadly neutralizing human antibodies. It is under investigation for the treatment of Sudan ebolavirus (SUDV).
- Mechanism
- Curator reviewed
Pharmacologically active on Envelope glycoprotein
- Code names
- MBP-134
Resolves to
Targets
What you can answer from here — as of November 11, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with MBP134, and which of those have an active Phase 3 trial?